S-1521 : Still Just a Bill

Gabriella Miller Kids First Research Act 2.0

This bill modifies funding for a pediatric disease research initiative within the National Institutes of Health (NIH).

Currently, this initiative receives funding through FY2023 from the 10-Year Pediatric Research Initiative Fund.

This bill directs certain penalties assessed by the Securities and Exchange Commission against pharmaceutical companies for specified violations to that fund. In making allocations from the fund, the NIH must prioritize pediatric research that does not duplicate existing research activities.

Action Timeline

Action DateTypeTextSource
2021-04-29IntroReferralRead twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2365)Senate
2021-04-29IntroReferralIntroduced in SenateLibrary of Congress

Sponsor :

Tim Kaine [D] (VA)
See Cosponsors

Policy Area :

Health
Related Subjects
  • Banking and financial institutions regulation
  • Cancer
  • Child health
  • Civil actions and liability
  • Drug safety, medical device, and laboratory regulation
  • Government trust funds
  • Health programs administration and funding
  • Medical research
  • Research administration and funding
  • Securities
Related Geographic Entities
Related Organizations
  • Department of Health and Human Services
  • National Institutes of Health (NIH)
  • Securities and Exchange Commission (SEC)

Related Bills

See Related Bills